Cargando…

Number needed to vaccinate for COVID-19 booster doses: a valuable metric to inform vaccination strategies

Detalles Bibliográficos
Autores principales:	Feng, Shuo, Lin, E., Cowling, Benjamin J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10304837/ https://www.ncbi.nlm.nih.gov/pubmed/37397875 http://dx.doi.org/10.1016/j.lana.2023.100548

Ejemplares similares

Booster doses for inactivated COVID-19 vaccines: if, when, and for whom
por: Croda, Julio, et al.
Publicado: (2022)

COVID-19 vaccine booster strategy: striving for best practice
por: Tanriover, Mine Durusu, et al.
Publicado: (2022)

Protein-based vaccine as the booster dose for adults: evidence and beyond
por: Shang, Lianhan, et al.
Publicado: (2022)

Safety and reactogenicity of second booster doses for mRNA vaccines
por: Wilder-Smith, Annelies, et al.
Publicado: (2023)

Updated report of COVID-19 vaccine safety monitoring in Japan: booster doses for Omicron variants and vaccinations for infants and young children
por: Yamaguchi, Toshihiro, et al.
Publicado: (2023)

What a second booster dose of mRNA COVID-19 vaccines tells us
por: Loubet, Paul, et al.
Publicado: (2022)

Waning immunity to SARS-CoV-2: implications for vaccine booster strategies
por: Altmann, Daniel M, et al.
Publicado: (2021)

How repeated influenza vaccination effects might apply to COVID-19 vaccines
por: Thompson, Mark G, et al.
Publicado: (2022)

Single-dose Oxford–AstraZeneca COVID-19 vaccine followed by a 12-week booster
por: Hung, Ivan F N, et al.
Publicado: (2021)

COVID-19 vaccine results might inform malaria vaccine strategies
por: Abeywickrema, Movin, et al.
Publicado: (2022)

Cost effectiveness of fractional doses of COVID-19 vaccine boosters in India
por: Du, Zhanwei, et al.
Publicado: (2023)

Updated report of COVID-19 vaccine safety monitoring in Japan: Booster shots and paediatric vaccinations
por: Yamaguchi, Toshihiro, et al.
Publicado: (2022)

COVID-19 vaccine boosters in the Asia-Pacific region in the context of Omicron
por: Hart, John D, et al.
Publicado: (2022)

Boosters appear effective, but are they always needed?
por: Reddy, K Srinath
Publicado: (2021)

The potential of Beta variant containing COVID booster vaccines for chasing Omicron in 2022
por: Sridhar, Saranya, et al.
Publicado: (2022)

Could Beta variant containing COVID-19 booster vaccines tackle Omicron variants?
por: Jin, Pengfei, et al.
Publicado: (2023)

Safety of COVID-19 booster dose: is the juice worth the squeeze?
por: Madhi, Shabir A, et al.
Publicado: (2023)

Effectiveness of bivalent mRNA booster vaccines against COVID-19: methodological and public health considerations
por: Stoliaroff-Pepin, Anna, et al.
Publicado: (2023)

Bivalent omicron (BA.1) booster vaccination against SARS-CoV-2
por: Vasin, Andrey V, et al.
Publicado: (2023)

Modelling vaccination strategies for COVID-19
por: Wagner, Caroline E., et al.
Publicado: (2022)

Effectiveness of mRNA booster doses against the omicron variant
por: Zedan, Hadeel T, et al.
Publicado: (2022)

Hybrid immunity and strategies for COVID-19 vaccination
por: Hui, David S
Publicado: (2023)

An urgent need: vaccines for neglected tropical diseases
por: Anderson, Roy M
Publicado: (2021)

Children vaccination as a population strategy to increase COVID-19 vaccine coverage in Brazil
por: Guimarães, Raphael Mendonça
Publicado: (2022)

Immunogenicity and safety of BNT162b2 mRNA vaccine booster in actively treated patients with cancer
por: Ligumsky, Hagai, et al.
Publicado: (2022)

EPH172 When Is It Valuable for COVID-19 Booster Dose?: A Transmission Dynamics Model-Based Effectiveness and Cost-Effectiveness Analysis of Two Booster Dose Vaccination Priority Strategies in Mainland China
por: Zhou, D, et al.
Publicado: (2022)

Trimeric S protein COVID-19 vaccine needs to find its place
por: Vesikari, Timo
Publicado: (2022)

Strategies to minimize inequity in COVID-19 vaccine access in the US: Implications for future vaccine rollouts
por: Chhibber, Anindit, et al.
Publicado: (2021)

Serological response following anti-SARS-CoV-2 vaccination in hematopoietic stem cell transplantation patients depends upon time from transplant, type of transplant and “booster”dose
por: Attolico, Immacolata, et al.
Publicado: (2022)

Southeast Asia needs a revolving fund for vaccines
por: Seraj Ahmad, Fariza Nasreen, et al.
Publicado: (2022)

Booster Covid Vaccination- Luxury or Need?
por: Karn, Mitesh, et al.
Publicado: (2021)

Rational use of face masks in the COVID-19 pandemic
por: Feng, Shuo, et al.
Publicado: (2020)

Assortative mixing among vaccination groups and biased estimation of reproduction numbers
por: Klaus, Colin, et al.
Publicado: (2022)

Are COVID-19 Vaccine Boosters Needed? The Science behind Boosters
por: Burckhardt, Rachel M., et al.
Publicado: (2022)

Impact of methotrexate on first-dose COVID-19 mRNA vaccination
por: Connolly, Caoilfhionn M, et al.
Publicado: (2021)

Severe mental illness and European COVID-19 vaccination strategies
por: De Picker, Livia J, et al.
Publicado: (2021)

Responsive and agile vaccination strategies against COVID-19 in India
por: Mandal, Sandip, et al.
Publicado: (2021)

Adapted vaccine strategy: facing the persistent challenges of COVID-19
por: Shang, Lianhan, et al.
Publicado: (2023)

A Higher Number of Covid19 Cases and Fatalities in Israel Phased With the Start of the Mass Vaccination
por: Boretti, Alberto
Publicado: (2021)

Urgent needs of low-income and middle-income countries for COVID-19 vaccines and therapeutics
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tsht8nnlvnjt7jvrg7vmnl0r3r